Dieta aterogénica y alteración de los índices de riesgo cardiovascular / Atherogenic diet and alteration of cardiovascular risk indexes

Introducción: una alimentación muy selectiva y poco variada durante la primera infancia, puede modificar seriamente los índices de riesgo cardiovascular, ante lo cual, la detección de la alteración lipídica es de suma importancia para promover e implementar el cambio de hábitos. Caso clínico: se presenta una niña de 6 años con una dieta a base de alimentos industriales, a quien se le realizó un perfil lipídico, por considerar que la alimentación tan limitada que consumía era un factor de riesgo aterogénico. Esto permitió diagnosticar una marcada disminución del HDL-colesterol, hipertrigliceridemia y franca alteración de los índices de riesgo. Discusión: existe una relación directa entre la hipertrigliceridemia y el consumo de azúcares simples, presentes en las golosinas, postres o gaseosas. Además, las grasas saturadas e industriales (trans) son responsables de la disminución del colesterol HDL. Llamó la atención la contundencia que ejerció la alteración del laboratorio, sobre el accionar de los padres. Luego de 6 meses de poner en práctica las indicaciones, los valores y los índices de riesgo se normalizaron. Conclusiones: se destaca la importancia de realizar un perfil lipídico en niños mayores de 2 años cuando se detecta el consumo de una dieta aterogénica, dado que el descenso de colesterol HDL tiene relación directa con la alimentación y el estilo de vida. Un valor inferior a 45 mg/dL es un factor de riesgo que puede ser modificado(AU)

Introduction: a very selective and little varied diet during early childhood can seriously modify the cardiovascular risk indexes, and because of that the detection of lipid alteration is very important to promote and implement the change of habits. Clinical case: a 6-year-old girl was presented with a diet based on industrial foods. A lipid profile was made considering that the very limited diet she consumed was an atherogenic risk factor. This allowed diagnosing a marked decrease in HDL-cholesterol, hypertriglyceridemia and real alteration in the risk indexes. Discussion: there is a direct relation among hypertriglyceridemia and the consumption of simple sugars, which are present in sweets, desserts or sodas. In addition, saturated and industrial (trans) fats are responsible for lowering HDL cholesterol. It was significant the impact of the alteration in the laboratory results in the actions taken by the parents. After 6 months of putting the indications into practice, the values and risk indexes were normalized. Conclusions: it is highlighted the importance of performing a lipid profile in children older than 2 years when the consumption of an atherogenic diet is detected, since the decrease in HDL cholesterol is directly related to diet and lifestyle. A value below 45 mg/dL is a risk factor that can be modified(AU)

Grape extract and α-Tocopherol effect in cardiovascular disease model of Apo E -/- Mice / Efeito do extrato de uva e α-Tocoferol em camundongos Apo E -/-, modelo de doença cardiovascular

PURPOSE: To verify the effect of consumption of grape extract isolated or combined with α-tocopherol supplementation on atherosclerosis model with Apo E -/- mice. METHODS: After six weeks of atherogenic diet, Apo E -/- mice were divided into the following groups: Control, Grape, Tocopherol and Grape plus Tocopherol. The treatment progressed for 11 weeks when animals were submitted to euthanasia. RESULTS: All the treatments presented hypocholesterolemic effect with reduction of serum and liver cholesterol levels. This effect was parallel to an increase in the fecal excretion of cholesterol. There was also a higher fecal excretion of saturated fatty acids in groups receiving grape extract or α-tocopherol. All the groups treated presented a tendency to show higher levels of vitamin E. The fatty acid profile showed a tendency for monounsaturated fatty acid preservation after grape extract and α-tocopherol consumption. Morphological analysis revealed a lower degree of evolution of the atherosclerotic plaque of the animals that were fed α-tocopherol combined with grape extract, even when no difference was found in the size of the largest lesion. CONCLUSION: A synergistic effect between the polyphenols and α-tocopherol was observed, resulting in diminished evolution of atherosclerosis and a greater beneficial effect on atherosclerosis than the isolated consumption of antioxidants.

OBJETIVO: Verificar o efeito do consumo de extrato de uva isolada ou combinada com a suplementação de α-tocoferol em modelo de aterosclerose, utilizando camundongos Apo E -/-. MÉTODOS: Os camundongos Apo E -/- foram tratados com dieta aterogênica por seis semanas e foram divididos em quatro grupos: Controle, Uva, Tocoferol e Uva e Tocoferol. Após 11 semanas de tratamento os animais foram submetidos à eutanasia. RESULTADOS: Todos os tratamentos apresentaram efeito hipocolesterolêmico, com redução de colesterol plasmático e hepático. Este efeito foi acompanhado de um aumento na excreção fecal de colesterol. Houve também uma maior excreção fecal de ácidos graxos saturados nos grupos que receberam extrato de uva ou de α-tocoferol. Todos os grupos apresentaram uma tendência a apresentar níveis mais elevados de vitamina E. O perfil de ácidos graxos mostrou uma tendência para a preservação de ácidos graxos monoinsaturados, após consumo de extrato de uva e α-tocoferol. A análise morfológica revelou um menor grau de evolução da placa aterosclerótica dos animais que foram alimentados com α-tocoferol combinado com extrato de uva, mesmo quando não houve diferença no tamanho da lesão. CONCLUSÃO: Foi observado um efeito sinergístico entre os polifenóis e α-tocoferol, resultando na redução na evolução da aterosclerose e um maior de efeito benéfico na aterosclerose do que o consumo isolado de antioxidantes sobre a aterosclerose do que o consumo isolado de antioxidantes.

El propóleos reduce la esteatosis hepática inducida por dieta en ratones / Propolis decrease diet-induced hepatic steatosis in mice

El hígado graso no alcohólico (HGNA), comprende un amplio espectro de lesiones, que van desde esteatosis hepática, hasta cirrosis y carcinoma hepatocelular, siendo sus principales factores de riesgo los desordenes asociados a síndrome metabólico (SM). El propóleos, sustancias resinosa elaborada por Apis mellifera para la protección de la colmena, ha demostrado un efecto hepatoprotector, así el objetivo de esta investigación fue evaluar el efecto de un propóleos chileno sobre el desarrollo de esteatosis hepática no alcohólica en ratones C57BL/6J sometidos a una dieta aterogénica tipo Paigen. Veintiocho ratones (C57BL/6J), divididos en: 1, dieta balanceada (CH); 2, dieta hipercolesterolémica (HC); 3, dieta HC + 10 mg/kg/día de propóleos (BP); 4, dieta HC + 40 mg/kg/día de propóleos (AP). Después de 16 semanas, se determinó la concentración de glucosa, colesterol total, triglicéridos y los niveles de alanina aminotransferasa (ALAT). El tejido hepático fue fijado en una solución de formalina tamponada al 10 por ciento para, posteriormente, ser incluido en paraplast y teñido con Hematoxilina-Eosina y fragmanetos congelados a -30C fijados en formalina teñidos con tinción Oil red O. No existieron diferencias en la concentración de glucosa ni triglicéridos, a diferencia del colesterol total, entre el grupo alimentado con dieta balanceada (CH) y los alimentados con la dieta aterogénica D12336 (HC, BP y AP). De la misma forma se observó que existen diferencias en los niveles de actividad de ALAT entre los grupos estudiados, destacando su reducción en los grupos suplementados con propóleos (BP y AP). De forma concordante, la histoarquitectura del grupo HC, mostró esteatosis simple y focos de infiltrado leucocitario en el lobulillo hepático, observándose una disminución gradual de las alteraciones en los grupos de BP y AP. En conclusión, el propóleos chileno estudiado disminuye la esteatosis hepática inducida por la dieta aterogénica tipo Paigen en ratones C57BL/6J, sin embargo, los mecanismos implicados en esta actividad hepatoprotectora tienen que ser identificados.

Nonalcoholic fatty liver disease (NAFLD) covers a wide spectrum of injuries ranging from simple steatosis to cirrhosis and hepatocellular carcinoma. Its main risk factors are disorders associated with metabolic syndrome (MS). Propolis, a resinous substance produced by Apis mellifera to protect is hive, has demonstrated a hepatoprotective effect. Thus, the aim of this study was to evaluate the effect of Chilean propolis on development of nonalcoholic hepatic steatosis in C57BL/6J mice exposed to Paigen atherogenic diet. Twenty eight mice C57BL/6J were divided four groups: 1, balanced diet (CH); 2, hypercholesterolemic diet (HD); 3, HD diet supplemented with 10 mg/kg/day of propolis (LP); 4, HD diet supplemented with 40 mg/kg/day of propolis (HP). After 16 weeks of treatment was determined glucose, total cholesterol and triglycerides concentrations and alanine aminotransferase (ALT) activity. The liver tissue was fixed in 10 percent buffered formalin solution, embedded in paraplast and stained with hematoxylin-eosin. No differences was detected in glucose and triglycerides concentrations, contrasting with total cholesterol levels between group fed with a balanced diet (CH) and feed with atherogenic diet D12336 (HD, LP and HP). In the same way, it was noted differences in ALT activity between groups, standing out the reduction in propolis supplemented groups (LP and HP). Likewise the histoarchitecture of HD group, showed simple steatosis, inflammatory cell infiltration and inflammatory foci in hepatic lobule. This characteristics show a gradual decrease in LP and HP groups. In conclusion, the Chilean propolis analyzed decreases hepatic steatosis induced by atherogenic diet in C57BL/6J mice. However, the involved mechanisms in this hepatoprotective activity must be identified.